Hart W J, Jones R S
The Robert Jones and Agnes Hunt Orthopaedic and District Hospital, Oswestry, Shropshire SY10 7AG, UK.
J Bone Joint Surg Br. 2006 Aug;88(8):1011-5. doi: 10.1302/0301-620X.88B8.17445.
We present a series of 48 patients with infected total knee replacements managed by the use of articulating cement spacers and short-term parenteral antibiotic therapy in the postoperative period. All patients had microbiological and/or histological confirmation of infection at the first stage of their revision. They all underwent re-implantation and had a mean follow-up of 48.5 months (26 to 85). Infection was successfully eradicated in 42 of the 48 patients (88%). Six had persistent infection which led to recurrence of symptoms and further surgery was successful in eliminating infection in four patients. These rates of success are similar to those of other comparable series. We conclude that protracted courses of intravenous antibiotic treatment may not be necessary in the management of the infected total knee replacement. In addition, we analysed the microbiological, histological and serological results obtained at the time of re-implantation of the definitive prosthesis, but could not identify a single test which alone would accurately predict a successful outcome.
我们报告了一系列48例感染性全膝关节置换患者,在术后使用关节式骨水泥间隔物及短期肠外抗生素治疗。所有患者在翻修第一阶段均有微生物学和/或组织学感染确诊。他们均接受了再次植入,平均随访48.5个月(26至85个月)。48例患者中有42例(88%)感染成功根除。6例持续感染导致症状复发,4例患者再次手术成功消除感染。这些成功率与其他类似系列相似。我们得出结论,在感染性全膝关节置换的治疗中,可能无需长时间的静脉抗生素治疗疗程。此外,我们分析了在最终假体再次植入时获得的微生物学、组织学和血清学结果,但未能确定单一一项检查能准确预测成功结果。